/BIOWKS.ST
BIOWKS.ST Stock - Bio-Works Technologies AB (publ)
Healthcare|BiotechnologySTO
$2.25-1.32%
$0.03 (-1.32%) • Dec 23
61
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.47
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.73
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $2.48
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for BIOWKS.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$2.23 – $2.27
TARGET (TP)$2.59
STOP LOSS$2.07
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.17
52W High$3.56
52W Low$0.75
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $25.46M | $43.90M | $41.32M | $21.91M | $7.23M |
| Gross Profit | $20.02M | $26.82M | $28.85M | $18.56M | $4.22M |
| Gross Margin | 78.6% | 61.1% | 69.8% | 84.7% | 58.3% |
| Operating Income | $-37,996,000 | $-55,417,000 | $-47,143,000 | $-10,957,000 | $-45,654,000 |
| Net Income | $-37,357,000 | $-56,821,000 | $-44,950,000 | $-12,942,000 | $-44,549,000 |
| Net Margin | -146.7% | -129.4% | -108.8% | -59.1% | -615.8% |
| EPS | $-0.48 | $-1.57 | $-1.28 | $-0.41 | $-1.46 |
Company Overview
Bio-Works Technologies AB (publ), a biotechnology company, researches, develops, manufactures, and supplies agarose-based separation products to purify proteins, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; BabyBio columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; OptioBio glass columns; screening kits; and size exclusion chromatography resins. The company's products are used in antibodies, his-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines applications. Bio-Works Technologies AB (publ) founded in 2006 and is headquartered in Uppsala, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
BIOWKS.STBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.09
Q2 2025
EPS Surprise History
Q2 23
No data
Q3 23
No data
Q4 23
No data
Q1 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q2 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | Jun 30, 2025 | — | $-0.09 | — | — |
Q2 2025 | May 15, 2025 | — | $-0.10 | — | — |
Q1 2025 | Feb 21, 2025 | — | $-0.17 | — | — |
Q4 2024 | Nov 6, 2024 | — | $-0.12 | — | — |
Q3 2024 | Aug 23, 2024 | — | — | — | — |
Q2 2024 | May 24, 2024 | — | — | — | — |
Q1 2024 | Feb 19, 2024 | — | $-0.38 | — | — |
Q4 2023 | Oct 9, 2023 | — | $-0.38 | — | — |
Q3 2023 | Aug 18, 2023 | — | $-0.41 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.82 | — | — |
Q1 2023 | Feb 17, 2023 | — | $-0.30 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.61 | — | — |
Q3 2022 | Aug 19, 2022 | — | $-0.34 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.67 | — | — |
Q1 2022 | Feb 18, 2022 | — | $-0.34 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.68 | — | — |
Q3 2021 | Aug 20, 2021 | — | $0.15 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.28 | — | — |
Q1 2021 | Feb 19, 2021 | — | $-0.39 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.39 | — | — |
Latest News
Loading news...
Frequently Asked Questions about BIOWKS.ST
What is BIOWKS.ST's current stock price?
Bio-Works Technologies AB (publ) (BIOWKS.ST) is currently trading at $2.25 per share. The stock has moved -1.32% today.
What is the analyst price target for BIOWKS.ST?
No analyst price targets are currently available for this stock.
What sector is Bio-Works Technologies AB (publ) in?
Bio-Works Technologies AB (publ) operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the STO exchange.
What is BIOWKS.ST's market cap?
Bio-Works Technologies AB (publ) has a market capitalization of $0.18 billion, making it a small-cap company.
Does BIOWKS.ST pay dividends?
No, Bio-Works Technologies AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorALZ.ST
Alzinova AB (publ)
$0.82
Mkt Cap: $0.1B
ANNX.ST
Annexin Pharmaceuticals AB (publ)
$19.00
Mkt Cap: $0.1B
CLS-B.ST
Clinical Laserthermia Systems AB (publ)
$7.00
Mkt Cap: $0.2B
INIT.ST
Initiator Pharma A/S
$2.93
Mkt Cap: $0.2B
IRLAB-A.ST
IRLAB Therapeutics AB (publ)
$1.97
Mkt Cap: $0.2B
ISOFOL.ST
Isofol Medical AB (publ)
$0.72
Mkt Cap: $0.2B
IZAFE-B.ST
iZafe Group AB (publ)
$0.47
Mkt Cap: $0.1B
KDEV.ST
Karolinska Development AB (publ)
$0.43
Mkt Cap: $0.1B
LIPUM.ST
Lipum AB (publ)
$14.55
Mkt Cap: $0.3B
SENZA.ST
SenzaGen AB
$5.98
Mkt Cap: $0.2B
Explore stocks similar to BIOWKS.ST for comparison